Clinithink is hosting a luncheon presentation at SCOPE 2017 whereby Dr Steve Coca of Mount Sinai will present findings on using CLiX accelerate for Clinical Trials to dramatically accelerate patient recruitment.
New York, NY, 13 December 2016 - Clinithink, a market leading clinical trial patient recruitment solution provider, together with partners at the Icahn School of Medicine at Mount Sinai will demonstrate a marked improvement in the speed and quality of patient recruitment. Using CLiX accelerate to securely and accurately process unstructured patient data, investigative sites, like Mount Sinai, can now find 10X more patients matching clinical trial protocols in ¼ of the time it takes using current methods.
Revolutionizing what is a largely manual review process, Dr. Steve Coca, Associate Professor of Medicine, Nephrology at Mount Sinai, will share two unique case studies in a presentation entitled, ‘A Breakthrough in Technology Enabled Clinical Trials Recruitment,’ on Day 2 of the SCOPE 2017 Summit.
The 8th annual Summit for Clinical Ops Executives (SCOPE) will be held on January 24-26, 2017 in Miami, Florida. Renowned for providing valuable insight to members of the research community, SCOPE organisers are expecting 1,150 industry professionals and key thought leaders from over 500 organisations to gather and address critical issues facing the industry.
Effective, timely patient recruitment and enrollment are well-known barriers to drug development but by automating the search for eligible patients using existing unstructured data CLiX accelerate is setting a new precedent in finding patients that meet inclusion and exclusion criteria quickly and seamlessly.
Delegates to the Summit are invited to join Clinithink’s luncheon presentation on Wednesday the 25th of January at 12:10pm within the Patient Recruitment track in the ‘Recruitment in Resource-Constrained Environment: Traditional tactics, Analytics, Engagement’ session or contact marketing@clinithink.com to find out more.